Literature DB >> 17340785

The use of race in medicine as a proxy for genetic differences.

Michael Root1.   

Abstract

Race is a prominent category in medicine. Epidemiologists describe how rates of morbidity and mortality vary with race, and doctors consider the race of their patients when deciding whether to test them for sickle-cell anemia or what drug to use to treat their hypertension. At the same time, critics of racial classification say that race is not real but only an illusion or that race is scientifically meaningless. In this paper, I explain how race is used in medicine as a proxy for genes that encode drug metabolizing enzymes and how a proper understanding of race calls into doubt the practice of treating race as a marker of any medically relevant genetic trait.

Entities:  

Mesh:

Year:  2003        PMID: 17340785     DOI: 10.1086/377398

Source DB:  PubMed          Journal:  Philos Sci        ISSN: 0031-8248            Impact factor:   1.317


  5 in total

1.  The challenges of choosing and explaining a phenomenon in epidemiological research on the "Hispanic Paradox".

Authors:  Sean A Valles
Journal:  Theor Med Bioeth       Date:  2016-04

2.  Are the Origins of Precision Medicine Found in the Corpus Hippocraticum?

Authors:  Meropi K Konstantinidou; Makrina Karaglani; Maria Panagopoulou; Aliki Fiska; Ekaterini Chatzaki
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 3.  APOL1 Genetic Testing in Living Kidney Transplant Donors.

Authors:  Sumit Mohan; Ana S Iltis; Deirdre Sawinski; James M DuBois
Journal:  Am J Kidney Dis       Date:  2019-04-11       Impact factor: 8.860

4.  Perceptions of genetic testing and genomic medicine among drug users.

Authors:  David C Perlman; Camila Gelpí-Acosta; Samuel R Friedman; Ashly E Jordan; Holly Hagan
Journal:  Int J Drug Policy       Date:  2014-06-24

5.  Variation of ApoL1 Testing Practices for Living Kidney Donors.

Authors:  Tristan McIntosh; Sumit Mohan; Deirdre Sawinski; Ana Iltis; James M DuBois
Journal:  Prog Transplant       Date:  2019-12-16       Impact factor: 1.187

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.